Equities analysts expect Nektar Therapeutics (NASDAQ:NKTR – Get Rating) to post $23.38 million in sales for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Nektar Therapeutics’ earnings, with the highest sales estimate coming in at $26.60 million and the lowest estimate coming in at $21.29 million. Nektar Therapeutics posted sales of […]
Brokerages predict that Nektar Therapeutics (NASDAQ:NKTR – Get Rating) will report earnings of ($0.79) per share for the current quarter, Zacks reports. Six analysts have made estimates for Nektar Therapeutics’ earnings. The lowest EPS estimate is ($0.89) and the highest is ($0.66). Nektar Therapeutics reported earnings per share of ($0.68) during the same quarter last […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Brokerages expect Nektar Therapeutics (NASDAQ:NKTR – Get Rating) to announce sales of $23.38 million for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Nektar Therapeutics’ earnings. The highest sales estimate is $26.60 million and the lowest is $21.29 million. Nektar Therapeutics reported sales of $23.65 million in the same quarter […]